Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Switzerland / NCT06500910
Recruiting Not applicable

Exercise in Prematurely Born Preadolescents to Mitigate Cardiovascular Risk and Improve Cognitive Impairment

NCT06500910 · tracked via the Priya Life Science Switzerland tracker
Sponsor
Henner Hanssen
Phase
Not applicable
Started
2024-08-12
Last updated
2025-05-30

Condition(s) studied

Preterm Birth

Investigational drug(s) / intervention(s)

Physical Exercise

Physical Exercise: 10 weeks of child-friendly physical exercise program

Study summary

EXCELSIOR is a randomized controlled trial to investigate the effect of physical exercise on cardiovascular health in prematurely born children. Participants will be randomly allocated to either an intervention group or a control group. The intervention will receive a child-friendly physical exercise program and the control group will receive age appropriate lifestyle- and exercise recommendations.

Eligibility

Sex
ALL
Min age
6 Years
Max age
12 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Boys and girls born prematurely (\<= 32th week of gestation) * aged 6 to 12 years * informed consent provided Exclusion Criteria: * attendance of special education services related to attention disorders * colour blindness or any chronic eye disorder * being under pharmacological treatment for any mental disorder * injuries, significant motor- or other disabilities which prohibit the participation in physical exercise * visually provoked epilepsy * children for whom no informed consent is provided

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bereich Sport- und Bewegungsmedizin, Abteilung Präventive Sportmedizin & Systemphysiologie Basel Canton of Basel-City Recruiting

More Henner Hanssen trials in Switzerland

Exercise Training in Patients With Glaucoma Active, not recruiting

Other trials for the same condition

Movement Imitation Therapy for Preterm Babies (MIT-PB) - A Pilot Study Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06500910 on ClinicalTrials.gov ↗ ← All trials in Switzerland